Review Provides 'Even Greater Confidence' on Benefits of 'Ortho-K' for Kids with Myopia
A technique called orthokeratology ("Ortho-K")—using custom-made contact lenses to shape the growing eye—has a significant effect in slowing the progression of myopia (nearsightedness) in children, according to a research review in the March issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.
Led by Xing-Rong Wang, MD, of the Affiliated Eye Hospital of Shangdong University of Traditional Chinese Medicine in Jinan, China, the researchers analyzed pooled data from previous studies of Ortho-K. "They conclude, with even greater confidence, that orthokeratology does certainly slow myopia progression and retard the axial length growth of the eye," comments Anthony Adams, OD, PhD, Editor-in-Chief of Optometry and Vision Science.
'Ortho-K' for Myopia in Children—Pooled Research Review
Dr. Wang and colleagues analyzed seven previous studies of orthokeratology to treat myopia (nearsightedness) in children. Myopia is one of the most common eye disorders worldwide, with a reported prevalence of 20 to 50 percent in the United States and Europe, and 70 percent or higher in East Asia. Of the seven studies, five were performed in East Asia.
Ortho-K is a relatively new treatment approach, in which the child wears customized contact lenses overnight. Over time, the Ortho-K lenses act to guide eye growth—similar to the use of a dental "retainer" to straighten the teeth. Previous studies have reported encouraging results with Ortho-K in slowing myopia progression.
The seven studies included data on 435 children with mild to moderate myopia, aged six to 16 years. All studies assessed axial length, or the length of the eye from front to back. This is a key measure of eye growth, specifically of interest related to myopia development. The researchers used a method called meta-analysis to pool the study results from the publications they reviewed.
Results Support Ortho-K's Effect in Slowing Eye Growth
As expected, with or without orthokeratology, axial length increased as the children grew. However, after two years, the increase in axial length was significantly slower in children treated with Ortho-K. The average (weighted mean) difference between groups was about one-fourth of a millimeter.
That small but significant change was consistent with the reported effects of Ortho-K in slowing myopia progression. An alternative measure of eye growth (vitreous chamber depth) showed a similar difference between groups.
For reasons that are not yet entirely clear, childhood myopia has increased to epidemic proportions in recent years, especially in Asia. Myopia persists into adulthood and, in the more severe cases, is a risk factor for eye diseases such as cataracts, glaucoma, and retinal detachments.
Eye and vision researchers have been working on new optical treatment approaches to slow myopia progression. Ortho-K is one promising approach; others include contact lens designs that modify the focus on the peripheral retina.
The new review and meta-analysis supports the effectiveness of Ortho-K in producing at least some reduction in the rate of progressive myopia. "Most critically for myopia progression is the impact in retarding the growth of the eye, not just reshaping the cornea" says Dr. Adams.
That's an important piece of information, because questions remain as to the mechanism by which Ortho-K works to control myopic eye growth. Dr. Wang and coauthors emphasize the need for additional studies to address this issue, as well as large-scale randomized trials to assess its long-term benefits.
Article: "Orthokeratology for Myopia Control: A Meta-analysis" (doi: 10.1097/OPX.0000000000000505)
About Optometry and Vision Science
Optometry and Vision Science, official journal of the American Academy of Optometry, is the most authoritative source for current developments in optometry, physiological optics, and vision science. This frequently cited monthly scientific journal has served primary eye care practitioners for more than 75 years, promoting vital interdisciplinary exchange among optometrists and vision scientists worldwide.
About the American Academy of Optometry
Founded in 1922, the American Academy of Optometry is committed to promoting the art and science of vision care through lifelong learning. All members of the Academy are dedicated to the highest standards of optometric practice through clinical care, education or research.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medi-Span®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Follow our official Twitter handle: @WKHealth.